0.739
price up icon1.96%   0.0142
after-market Handel nachbörslich: .74 0.001 +0.14%
loading

Briacell Therapeutics Corp Aktie (BCTX) Neueste Nachrichten

pulisher
02:56 AM

Published on: 2025-08-14 21:54:42 - beatles.ru

02:56 AM
pulisher
04:50 AM

BriaCell Selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer - GlobeNewswire

04:50 AM
pulisher
Aug 13, 2025

BriaCell Joins MSK’s 2025 Therapeutics Accelerator Program - TipRanks

Aug 13, 2025
pulisher
Aug 13, 2025

BriaCell's Strategic Alliance with MSK and the Acceleration of Bria-OTS+ as a Game-Changer in Cancer Immunotherapy - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Progra - GuruFocus

Aug 13, 2025
pulisher
Aug 13, 2025

BriaCell joins Memorial Sloan Kettering’s Therapeutics Accelerator program By Investing.com - Investing.com South Africa

Aug 13, 2025
pulisher
Aug 13, 2025

Memorial Sloan Kettering Selects BriaCell's Novel Cancer Immunotherapy for 2025 Development Program - Stock Titan

Aug 13, 2025
pulisher
Aug 12, 2025

Will BriaCell Therapeutics Corp. Equity Warrant Sustain Its Chart BreakoutGrowth Based Stock Signal Screener Updated - 선데이타임즈

Aug 12, 2025
pulisher
Aug 08, 2025

BriaCell Shares Slide 22% After Announcing Dilutive Public Offering - MSN

Aug 08, 2025
pulisher
Aug 07, 2025

BriaCell Therapeutics To Carry Out 1-for-10 Reverse Stock Split On August 25th, 2025 - 富途牛牛

Aug 07, 2025
pulisher
Aug 06, 2025

BriaCell Announces Share Consolidation to Maintain Nasdaq Compliance - The Globe and Mail

Aug 06, 2025
pulisher
Aug 06, 2025

BriaCell Sets August 25 for Major 10:1 Share Consolidation: What Shareholders Must Know - Stock Titan

Aug 06, 2025
pulisher
Aug 05, 2025

BriaCell Announces Proposed Effective Date of Share Consolidation - GlobeNewswire

Aug 05, 2025
pulisher
Aug 05, 2025

My Honest Opinion of Energy Transfer Stock - The Globe and Mail

Aug 05, 2025
pulisher
Aug 05, 2025

Simon Property Reports Strong Q2 2025 Financial Results - The Globe and Mail

Aug 05, 2025
pulisher
Aug 03, 2025

What institutional investors are buying BriaCell Therapeutics Corp. Equity Warrant stockUnlock powerful stock screening techniques - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does BriaCell Therapeutics Corp. compare to its industry peersDiscover high-impact investment opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does BriaCell Therapeutics Corp. Equity Warrant generate profit in a changing economySuperior risk-adjusted returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

(BCT) Technical Pivots with Risk Controls (BCT:CA) - news.stocktradersdaily.com

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying BriaCell Therapeutics Corp. stockDiscover the next big stock winners - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes BriaCell Therapeutics Corp. stock price move sharplyCapitalize on emerging trends for profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is BriaCell Therapeutics Corp. Equity Warrant stock compared to the marketMassive portfolio appreciation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

BriaCell Therapeutics Corp. Equity Warrant Stock Analysis and ForecastGet daily updates on promising stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does BriaCell Therapeutics Corp. Equity Warrant compare to its industry peersHigh-octane gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes BriaCell Therapeutics Corp. Equity Warrant stock price move sharplyUnlock powerful market insights for success - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives BriaCell Therapeutics Corp. Equity Warrant stock priceMaximize returns with data-driven strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of BriaCell Therapeutics Corp. Equity Warrant stockMaximize gains with expert analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Published on: 2025-08-03 12:02:14 - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in BriaCell Therapeutics Corp. Equity Warrant stockAchieve consistent double-digit returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Should I hold or sell BriaCell Therapeutics Corp. Equity Warrant stock in 2025Tremendous return rates - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What catalysts could drive BriaCell Therapeutics Corp. Equity Warrant stock higher in 2025Invest smarter with comprehensive market analysis - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How does BriaCell Therapeutics Corp. generate profit in a changing economyProven strategies for superior portfolio growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What catalysts could drive BriaCell Therapeutics Corp. stock higher in 2025Sky-high return potential - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is BriaCell Therapeutics Corp. Equity Warrant stock overvalued or undervaluedRapid portfolio appreciation - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is it the right time to buy BriaCell Therapeutics Corp. Equity Warrant stockDouble-digit growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Off-market insider buying at Atico Mining (ATY) - The Globe and Mail

Aug 02, 2025
pulisher
Aug 01, 2025

BriaCell Therapeutics Corp. Recovery Hinges on Volume BreakoutWeekly Setup With 3x Return Potential Published - metal.it

Aug 01, 2025
pulisher
Aug 01, 2025

Is BriaCell Therapeutics Corp. a growth stock or a value stockPre Market Review For Consistent Profits - Jammu Links News

Aug 01, 2025
pulisher
Jul 31, 2025

BriaCell Expands Phase 3 Breast Cancer Study with UCLA Health Partnership - TipRanks

Jul 31, 2025
pulisher
Jul 31, 2025

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study - GlobeNewswire

Jul 31, 2025
pulisher
Jul 31, 2025

UCLA Health joins BriaCell’s phase 3 breast cancer study By Investing.com - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 31, 2025

UCLA Health joins BriaCell’s phase 3 breast cancer study - Investing.com

Jul 31, 2025
pulisher
Jul 31, 2025

FDA Fast-Tracked: UCLA Health to Test BriaCell's Novel Breast Cancer Immunotherapy in Pivotal Phase 3 Trial - Stock Titan

Jul 31, 2025
pulisher
Jul 31, 2025

Foraco International reports Q2 2025 - The Globe and Mail

Jul 31, 2025
$36.50
price up icon 0.11%
$86.16
price up icon 0.36%
$26.45
price down icon 1.56%
$127.75
price up icon 3.97%
$112.70
price down icon 0.07%
biotechnology ONC
$309.69
price up icon 0.71%
Kapitalisierung:     |  Volumen (24h):